Please wait
HEALTHCARE · Pharmaceutical Preparations · Price, fundamentals, signals, and forward-looking context in one research view.
HEALTHCARE
₦33.3B
N/A
34.01
Current price
₦7.90
+1.3% todayUpdated 30 min ago
Open
₦7.80
Previous close
₦7.80
Day range
₦7.80 – ₦7.90
Volume
820,388
34.0x P/E
Awaiting filing
No current yield
35/100 measured
Moderate liquidity
NEIMETH has a cautious over 30 days and cautious over one year.
7-day forecast is free
You can use the full 7-day forecast on the free plan. Upgrade to Pro to unlock the 30-day and 1-year views.
Expected move
-5.15%
Expected price
₦7.49
Lower path
₦6.93
Upper path
₦8.06
Confidence
Whisone is bullish because fundamentals are solid at 67/100 while today's volume is only 26% of average. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Sentiment
Market mood from flow, events, and attention.
Latest net profit
₦980M
TTM (2026-08-30)
ROE
37.2%
Return on equity
ROA
7.0%
Return on assets
Debt / equity
3.29
Lower is usually safer.
P/B ratio
11.75
Useful for book value support.
76/100
Direction
Cautious
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Fair value
₦7.79
Analyst view
n/a
Forecast refresh
Updated 2h ago
Quality score
72
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
44.1
Momentum is currently in a neutral range.
Recent trend
Falling
-14.1% across the latest saved price window.
Volatility
Low
Beta is 0.70. Price has historically moved more calmly than the wider market.
52-week position
26% of range
Price is sitting around the middle of its 52-week range.
Volume confirmation
0.26x average
Trading activity is light, so the current price move has weaker confirmation.
Capital raise
NEIMETH may benefit from capital raise. Confidence 90%.
Guinea Insurance completed a N12.6 billion capital raise and says this positions it above NAICOM's minimum capital requirement for non-life insurers.
Capital raising
NEIMETH may benefit from capital raising. Confidence 90%.
Shareholders approved plans to raise additional capital to accelerate expansion and complete the Amawbia manufacturing facility.
additional N30 billion capital raise
NEIMETH may benefit from additional n30 billion capital raise. Confidence 90%.
Shareholders unanimously approved an additional N30 billion capital raise, increasing the company's total fundraising mandate to N50 billion.
additional N30 billion capital raise (total mandate N50bn)
NEIMETH may benefit from additional n30 billion capital raise (total mandate n50bn). Confidence 90%.
Shareholders unanimously approved an additional N30 billion capital raise, lifting the company's total fundraising mandate to N50 billion.
additional N30bn capital raise (total N50bn mandate)
NEIMETH may benefit from additional n30bn capital raise (total n50bn mandate). Confidence 90%.
Shareholders approved the additional N30bn fundraising, expanding the company's fundraising mandate to N50bn.
Sector spillover signals
infrastructure
NEIMETH may also move because the HEALTHCARE sector may benefit from infrastructure. Confidence 90%.
The ICT group's infrastructure segment (data centre, network, security, storage) was the main driver of CWG's revenue growth, indicating stronger demand in ICT infrastructure.
manufacturing expansion
NEIMETH may also move because the HEALTHCARE sector may benefit from manufacturing expansion. Confidence 90%.
The board aims to complete a world-class pharmaceutical manufacturing facility in Amawbia as part of its expansion programme.
manufacturing infrastructure
NEIMETH may also move because the HEALTHCARE sector may benefit from manufacturing infrastructure. Confidence 90%.
Completion of a pharmaceutical manufacturing facility by Neimeth increases manufacturing capacity in the healthcare sector.
profit-taking
NEIMETH may also move because the HEALTHCARE sector may move with profit-taking. Confidence 85%.
Profit-taking is identified in the article as a trigger for the sell-off impacting SWOOT stocks.
high_energy_costs
NEIMETH may also move because the HEALTHCARE sector may move with high_energy_costs. Confidence 63%.
PMG-MAN stated the pharmaceutical sector spends a large share of revenue on energy, reducing competitiveness industry-wide.
q1_2026_gdp_growth
NEIMETH may also move because the HEALTHCARE sector may move with q1_2026_gdp_growth. Confidence 63%.
NBS data cited in the article shows the healthcare sector grew by 1.99% in Q1 2026 (vs 1.76% in Q1 2025), indicating sector-level growth dynamics affecting listed healthcare firms.
policy_stability_and_support
NEIMETH may also move because the HEALTHCARE sector may benefit from policy_stability_and_support. Confidence 60%.
The sector would benefit from extended Presidential Executive Order, dedicated energy tariffs, and policies encouraging local API production to attract investment and boost local manufacturing.
local manufacturing / import substitution
NEIMETH may also move because the HEALTHCARE sector may benefit from local manufacturing / import substitution. Confidence 56%.
The article notes Nigeria's pharmaceutical firms are investing in local manufacturing and import substitution to reduce dependence on foreign supply, a trend that supports domestic pharma firms' growth and access.
NEIMETH
Neimeth International Pharmaceuticals Plc
Price: ₦7.90
P/E: 34.01
Yield: N/A
EKOCORP
Eko Corporation Plc
Price: ₦5.80
P/E: N/A
Yield: N/A
FIDSON
Fidson Healthcare Plc
Price: ₦79.00
P/E: 18.33
Yield: 1.6%
MAYBAKER
May & Baker Nigeria Plc
Price: ₦37.00
P/E: 11.71
Yield: 1.1%
Industry
Pharmaceutical Preparations
Founded
1957
Employees
212
Exchange
NGX
Ticker
NEIMETH
0.66
